Independent validation of a prognostic genomic profile (ColoPrint) for stage II colon cancer (CC) patients

被引：2
|
作者：
Rosenberg, R.
Maak, M.
Nitsche, U.
Schuster, T.
Kuenzli, B.
Snel, M.
Simon, I.
Janssen, K.
Friess, H.
机构：
[1] Tech Univ Munich, Klinikum Rechts Isar, Dept Surg, D-80290 Munich, Germany
[2] Tech Univ Munich, Klinikum Rechts Isar, Dept Epidemiol & Stat, D-80290 Munich, Germany
[3] Agendia BV, Amsterdam, Netherlands
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2010年 / 28卷 / 15期
关键词：
D O I：
10.1200/jco.2010.28.15_suppl.3513
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3513
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Independent validation of a prognostic genomic profile (ColoPrint) for stage II colon cancer (CC) patients
    Rosenberg, R.
    Maak, M.
    Simon, I.
    Nitsche, U.
    Schuster, T.
    Kuenzli, B.
    Bender, R. A.
    Janssen, K.
    Friess, H.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (04)
  • [2] Independent validation of a prognostic genomic profile (ColoPrint) for stage II colon cancer patients
    Rosenberg, R.
    Maak, M.
    Simon, I.
    Nitsche, U.
    Schuster, T.
    Kuenzli, B.
    Keerl, A.
    Friess, H.
    Kocher, T.
    [J]. BRITISH JOURNAL OF SURGERY, 2012, 99 : 9 - 9
  • [3] Independent Validation of a Prognostic Genomic Signature (ColoPrint) for Patients With Stage II Colon Cancer
    Maak, Matthias
    Simon, Iris
    Nitsche, Ulrich
    Roepman, Paul
    Snel, Mireille
    Glas, Annuska M.
    Schuster, Tibor
    Keller, Gisela
    Zeestraten, Eliane
    Goossens, Ines
    Janssen, Klaus-Peter
    Friess, Helmut
    Rosenberg, Robert
    [J]. ANNALS OF SURGERY, 2013, 257 (06) : 1053 - 1058
  • [4] VALIDATION OF A ROBUST PROGNOSTIC GENOMIC SIGNATURE (ColoPrint) FOR STAGE II COLON CANCER PATIENTS IN INDEPENDENT PATIENT COHORTS
    Salazar, R.
    Roepman, P.
    Simon, I
    Moreno, V
    Capella, G.
    Moreno, V
    Westerga, J.
    Tollenaar, R.
    van't Veer, L.
    Glas, A.
    [J]. ANNALS OF ONCOLOGY, 2009, 20 : 16 - 16
  • [5] ADDITIONAL VALIDATION OF A GENOMIC SIGNATURE (COLOPRINT) FOR THE RISK STRATIFICATION OF STAGE II COLON CANCER PATIENTS
    Tabernero, J.
    Salazar, R.
    Roepman, P.
    Glas, A.
    Santos, C.
    Friess, H.
    Ramos, F.
    Capella, G.
    Simon, I
    Rosenberg, R.
    [J]. ANNALS OF ONCOLOGY, 2010, 21 : 17 - 17
  • [6] Clinical and technical validation of a genomic classifier (ColoPrint) for predicting outcome of patients with stage II colon cancer.
    Tabernero, Josep
    Moreno, Victor
    Rosenberg, Robert
    Nitsche, Ulrich
    Bachleitner-Hofmann, Thomas
    Lanza, Giovanni
    van den Akker, Jeroen
    Roepman, Paul
    Simon, Iris
    Salazar, Ramon
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (04)
  • [7] Validation of a genomic classifier (ColoPrint) for predicting outcome in the T3-MSS subgroup of stage II colon cancer patients
    Salazar, Ramon
    Tabernero, Josep
    Moreno, Victor
    Nitsche, Ulrich
    Bachleitner-Hofmann, Thomas
    Lanza, Giovanni
    Stork, Lisette
    Roepman, Paul
    Simon, Iris
    Rosenberg, Robert
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [8] Genomic classifier (ColoPrint) to predict outcome and chemotherapy benefit in stage II and III colon cancer patients
    Kopetz, Scott
    Jiang, Zhi-Qin
    Overman, Michael J.
    Rosenberg, Robert
    Salazar, Ramon
    Tabernero, Josep
    Stork, Lisette
    Li, Ying
    Simon, Iris
    Chang, George J.
    Maru, Dipen M.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [9] Genomic classifier (ColoPrint) predicts outcome and chemotherapy benefit in stage II and III colon cancer patients
    Kopetz, S.
    Jiang, Z. Q.
    Overman, M. J.
    Rosenberg, R.
    Salazar, R.
    Tabernero, J.
    Stork-Sloots, L.
    Simon, I.
    Chang, G. J.
    Maru, D. M.
    [J]. EUROPEAN JOURNAL OF CANCER, 2013, 49 : S514 - S515
  • [10] The PARSC trial, a prospective study for the assessment of recurrence risk in stage II colon cancer (CC) patients using ColoPrint
    Salazar, R.
    Marshall, J.
    Stork-Sloots, L.
    Simon, I.
    Holzik, M. Lutke
    Tabernero, J.
    Van Der Hoeven, J. J.
    Bibeau, F.
    Rosenberg, R.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
12345